Previous studies indicated that impairment of HSP-25 and HSP-72 was linked to obesity, insulin resistance and diabetes in humans and animals while their induction was associated with improved clinical outcomes. This evidence concerns the gene HSPB1 and obesity due to melanocortin 4 receptor deficiency.